SERB SA
9.7 FTEThe score of SERB shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Revenue +23 % Equity +32 % Total assets -11 % Headcount (avg FTE) +8 %
Accounts of the company itself (not consolidated). Consolidated group accounts are also filed: they are in the full file.
The full file covers 11 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
SERB's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | €96.9m | ||||
| Net result | €13.7m | ||||
| Equity | €49.5m | ||||
| Cash | €10.9m | ||||
| EBITDA | €35.0m | ||||
| Total assets | €159.3m |
Filed annual accounts
- Year ended 31 Dec 2025filed on 08 Jun 2026
- Year ended 31 Dec 2024filed on 04 Nov 2025
- Year ended 31 Dec 2023filed on 13 Jun 2024
- Year ended 31 Dec 2022filed on 06 Jun 2023
- Year ended 31 Dec 2021filed on 14 Jul 2022
SERB's financial analysis
- Solvency31.1%sector median: 32.3%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of SERB
SERB's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0538.813.719
- VAT number
- BE0538813719
- Peppol
- Registered · 0208:0538813719 · as of 10 Nov 2026
- Legal form
- SA
- Incorporated
- 20 Sep 2013
- Registered office
- 1050 Ixelles
- Size
- Micro · 9.7 FTE
- Latest accounts
- 2025 · filed on 08 Jun 2026
- Activity
- Wholesale of pharmaceutical and medical goods (NACE 46460)
SERB (SA) has been based in Ixelles since 2013, active in: wholesale of pharmaceutical and medical goods. For 2025, it reports revenue of €96.9m, a net profit of €13.7m and equity of €49.5m. With 9.7 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 31.1%, below the median of its sector (32.3%).
Companies similar to SERB
Companies in the same business, of comparable size and area, outside its group.
- PHOENIX Pharma Belgium Manufacture of pharmaceutical preparations Woluwe-Saint-Lambert · balance sheet €235.4m
- Vertex Pharmaceuticals (Belgium) Wholesale of pharmaceutical and medical goods Brussels · balance sheet €84.4m
- Novartis Pharma Wholesale of pharmaceutical and medical goods Machelen (Brab.) · balance sheet €168.8m
- V.M.D. Manufacture of pharmaceutical preparations Arendonk · balance sheet €28.5m
- Departement Central DE Fractionnement Manufacture of pharmaceutical preparations Brussels · balance sheet €19.7m
- Johnson & Johnson Medical Wholesale of pharmaceutical and medical goods Machelen (Brab.) · balance sheet €225.6m
- FertiPro Manufacture of other chemical products n.e.c. Beernem · balance sheet €15.9m
- Viatris Wholesale of pharmaceutical and medical goods Hoeilaart · balance sheet €141.1m
Frequently asked questions about SERB
What is the revenue of SERB?
According to the 2025 annual accounts filed with the NBB, the revenue of SERB amounts to 96,880,725 €.
What is the VAT number of SERB?
In Belgium, the VAT number is the company number prefixed with BE: BE0538813719 for SERB, if the company is VAT-registered. Its company number (CBE) is 0538.813.719.
Where is the registered office of SERB?
According to the CBE register, the registered office of SERB is in 1050 Ixelles.
What is the equity of SERB?
At the close of the 2025 financial year, the equity of SERB amounts to 49,543,416 €, a solvency of 31.1% of total assets.
How many people work at SERB?
9.7 full-time equivalents on average according to the 2025 social balance sheet.
Who manages SERB?
The register lists 4 active mandates at SERB. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of SERB
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →